Chandiok K, Marathe S, Rooney M, et al. Cannabis and its therapeutic value in the ageing population: attitudes of health-care providers. Austral J Age. 2021;40(3):261–74. https://doi.org/10.1111/ajag.12846.

Article  Google Scholar 

Costantino RC, Felten N, Todd M, et al. A survey of hospice professionals regarding medical cannabis practices. J Palliat Med. 2019;22(10):1208–12. https://doi.org/10.1089/jpm.2018.0535.

Article  PubMed  Google Scholar 

Karanges EA, Suraev A, Elias N, et al. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey. BMJ Open. 2018;8(7): e022101. https://doi.org/10.1136/bmjopen-2018-022101.

Article  PubMed  PubMed Central  Google Scholar 

Ziemianski D, Capler R, Tekanoff R, et al. Cannabis in medicine: a national educational needs assessment among Canadian physicians. BMC Med Educ. 2015;15:52. https://doi.org/10.1186/s12909-015-0335-0.

Article  PubMed  PubMed Central  Google Scholar 

Hallinan CM, Gunn JM, Bonomo YA. Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis. BMJ Open. 2021;11(10): e054044. https://doi.org/10.1136/bmjopen-2021-054044.

Article  PubMed  PubMed Central  Google Scholar 

Sajdeya R, Shavers A, Jean-Jacques J, et al. Practice patterns and training needs among physicians certifying patients for medical marijuana in Florida. J Prim Care Community Health. 2021;12:21501327211042790. https://doi.org/10.1177/21501327211042790.

Article  PubMed  PubMed Central  Google Scholar 

MacCallum CA, Lo LA, Boivin M. “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. Eur J Intern Med. 2021;89:10–8. https://doi.org/10.1016/j.ejim.2021.05.002.

Article  CAS  PubMed  Google Scholar 

MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12–9. https://doi.org/10.1016/j.ejim.2018.01.004.

Article  CAS  PubMed  Google Scholar 

Gottschling S, Ayonrinde O, Bhaskar A, et al. Safety considerations in cannabinoid-based medicine. Int J Gen Med. 2020;13:1317–33. https://doi.org/10.2147/ijgm.S275049.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hindley G, Beck K, Borgan F, et al. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. Lancet Psychiatry. 2020;7(4):344–53. https://doi.org/10.1016/s2215-0366(20)30074-2.

Article  PubMed  PubMed Central  Google Scholar 

Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannab Cannab Res. 2017;2(1):139–54. https://doi.org/10.1089/can.2016.0034.

Article  CAS  Google Scholar 

Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456–73. https://doi.org/10.1001/jama.2015.6358.

Article  CAS  PubMed  Google Scholar 

Winstock AR, Barratt MJ. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend. 2013;131(1):106–11. https://doi.org/10.1016/j.drugalcdep.2012.12.011.

Article  CAS  PubMed  Google Scholar 

Ergisi M, Erridge S, Harris M, et al. An updated analysis of clinical outcome measures across patients from the UK Medical Cannabis Registry. Cannab Cannab Res. 2022. https://doi.org/10.1089/can.2021.0145.

Article  Google Scholar 

Cahill SP, Lunn SE, Diaz P, et al. Evaluation of patient reported safety and efficacy of cannabis from a survey of medical cannabis patients in Canada. Front Public Health. 2021;9: 626853. https://doi.org/10.3389/fpubh.2021.626853.

Article  PubMed  PubMed Central  Google Scholar 

Bar-Lev Schleider L, Mechoulam R, Sikorin I, et al. Adherence, safety, and effectiveness of medical cannabis and epidemiological characteristics of the patient population: a prospective study. Front Med. 2022;9: 827849. https://doi.org/10.3389/fmed.2022.827849.

Article  Google Scholar 

Crescioli G, Lombardi N, Bettiol A, et al. Adverse events following cannabis for medical use in Tuscany: an analysis of the Italian Phytovigilance database. Br J Clin Pharmacol. 2020;86(1):106–20. https://doi.org/10.1111/bcp.14140.

Article  PubMed  PubMed Central  Google Scholar 

Banerjee R, Erridge S, Salazar O, et al. Real world evidence in Medical Cannabis Research. Therap Innov Regul Sci. 2022;56(1):8–14. https://doi.org/10.1007/s43441-021-00346-0.

Article  Google Scholar 

Bialas P, Fitzcharles MA, Klose P, et al. Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: a systematic review and meta-analysis of effectiveness and safety. Eur J Pain (London, England). 2022. https://doi.org/10.1002/ejp.1957

Safakish R, Ko G, Salimpour V, et al. Medical Cannabis for the management of pain and quality of life in chronic pain patients: a prospective observational study. Pain Med. 2020;21(11):3073–86. https://doi.org/10.1093/pm/pnaa163.

Article  PubMed  Google Scholar 

Sagy I, Bar-Lev Schleider L, Abu-Shakra M, et al. Safety and efficacy of medical cannabis in fibromyalgia. J Clin Med. 2019. https://doi.org/10.3390/jcm8060807.

Article  PubMed  PubMed Central  Google Scholar 

Bar-Sela G, Vorobeichik M, Drawsheh S, et al. The medical necessity for medicinal cannabis: prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care. Evid Based Complement Alternat Med eCAM. 2013;2013: 510392. https://doi.org/10.1155/2013/510392.

Article  PubMed  Google Scholar 

Devinsky O, Marmanillo A, Hamlin T, et al. Observational study of medical marijuana as a treatment for treatment-resistant epilepsies. Ann Clin Transl Neurol. 2022;9(4):497–505. https://doi.org/10.1002/acn3.51537.

Article  CAS  PubMed  PubMed Central  Google Scholar 

https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/information-medical-practitioners/information-health-care-professionals-cannabis-cannabinoids.html. Accessed 24 July 2023.

Quebec Medical College. Guidelines concerning the prescription of dried cannabis for medical purposes. Quebec: Quebec Medical College, 2014

Vigano A, Moride Y, Hachem Y, Canac-Marquis M, Gamaoun R, Kalaba M, Martel MO, Perez J, Néron A, Beaulieu P, Desroches J. The Quebec Cannabis Registry: investigating the safety and effectiveness of medical cannabis. Cannab Cannab Res. 2022. https://doi.org/10.1089/can.2022.0041.

Article  Google Scholar 

Health Canada. Information for Health Care Practitioners—Cannabis (marihuana, marijuana) and the cannabinoids. In: Canada H, ed. Internet: Health Canada, 2018.

College of Family Physicians of Canada. Authorizing dried cannabis for chronic pain or anxiety: preliminary guidance from the College of Family Physicians of Canada. Mississauga: College of Family Physicians of Canada, 2014.

U.S. Food and Drug Administration. What is a serious adverse event? In: FDA Website. FDA. 2016. https://www.fda.gov/safety/reporting-serious-problems-fda/what-serious-adverse-event. Accessed 03 Aug 2022.

Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20(2):109–17. https://doi.org/10.2165/00002018-199920020-00002.

Article  CAS  PubMed  Google Scholar 

Aviram J, Lewitus GM, Vysotski Y, et al. Sex differences in medical cannabis-related adverse effects. Pain. 2022;163(5):975–83. https://doi.org/10.1097/j.pain.0000000000002463.

Article  CAS  PubMed  Google Scholar 

Cooper ZD, Craft RM. Sex-dependent effects of cannabis and cannabinoids: a translational perspective. Neuropsychopharmacology. 2018;43(1):34–51. https://doi.org/10.1038/npp.2017.140.

Article  CAS  PubMed  Google Scholar 

Abuhasira R, Schleider LB-L, Mechoulam R, et al. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. Eur J Internal Med. 2018;49:44–50. https://doi.org/10.1016/j.ejim.2018.01.019.

Article  Google Scholar 

Bar-Lev Schleider L, Mechoulam R, Saban N, et al. Real life experience of medical cannabis treatment in autism: analysis of safety and efficacy. Sci Rep. 2019;9(1):200. https://doi.org/10.1038/s41598-018-37570-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bar-Lev Schleider L, Mechoulam R, Lederman V, et al. Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med. 2018;49:37–43. https://doi.org/10.1016/j.ejim.2018.01.023.

Article  PubMed  Google Scholar 

Bennici A, Mannucci C, Calapai F, et al. Safety of medical cannabis in neuropathic chronic pain management. Molecules (Basel, Switzerland). 2021. https://doi.org/10.3390/molecules26206257.

Article  PubMed  Google Scholar 

Zolotov Y, Eshet L, Morag O. Preliminary assessment of medical cannabis consumption by cancer survivors. Complement Ther Med. 2021;56: 102592. https://doi.org/10.1016/j.ctim.2020.102592.

Article  PubMed  Google Scholar 

Naftali T, Bar-Lev Schleider L, Sklerovsky Benjaminov F, et al. Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects. Eur J Gastroenterol Hepatol. 2019;31(11):1376–81. https://doi.org/10.1097/meg.0000000000001565[publishedOnlineFirst:2019/10/01].

Article  PubMed  Google Scholar 

Ware MA, Wang T, Shapiro S, et al. Cannabis for the management of pain: assessment of safety study (COMPASS). J Pain. 2015;16(12):1233–42. https://doi.org/10.1016/j.jpain.2015.07.014.

Article  PubMed  Google Scholar 

Olsson F, Erridge S, Tait J, Holvey C, et al. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry. Expert Rev Clin Pharmacol. 2023;16(3):257–66. https://doi.org/10.1080/17512433.2023.2183841.

Article